[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
Jul/Aug 2016

What Cost-Utility Analysis Can Teach Us About Facial Deformity: Gambles, Trade-offs, and Willingness to Pay

Author Affiliations
  • 1Division of Facial Plastic & Reconstructive Surgery; Department of Otolaryngology–Head & Neck Surgery, University of Michigan School of Medicine, Ann Arbor

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Facial Plast Surg. 2016;18(4):249-250. doi:10.1001/jamafacial.2016.0044

In the past 5 years, health care cost containment strategies have proliferated at an unprecedented rate in an effort to limit health care's gross domestic product footprint.1 The Medicare Authorization and CHIP Reauthorization Act (MACRA), which repealed the Sustainable Growth Rate Formula, includes far-reaching provisions to improve health care quality and value. For facial plastic surgery, these changes underscore the need to measure the value of facial reconstruction. Advances in facial plastic surgery optimize tissue perfusion in facial reconstruction2,3 and allow cost-based decision analysis for fracture management.4 But, how can we quantify the value of restoring a face?